Abstract Library

#27 Combined treatment of rapidly progressing neuroendocrine tumors by transcatheter arterial chemoembolisation of the liver and peptide-receptor radiotherapy is save and effective. Report of thirty consecutive patients

Introduction: Patients with rapidly progressing neuroendocrine tumors presenting with high tumor load and/or severe clinical syndromes are clinically challenging and with limited life expectany. Peptide receptor radiotherapy (PRRT) and transcatheter arterial chemoembolization (TACE) have demonstrated efficacy in the treatment of neuroendocrine tumors. However, there are no reports that both therapies have been applied in combination.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Hörsch D

Authors: Hörsch D, Gräber C, Prasad V, Gotthardt T, Petrovitch A,

Keywords: PRRT, TACE,